Poging GOUD - Vrij
PLI boost: Cancer drugs to cost less
Mint Hyderabad
|March 05, 2025
Cancer patients facing prohibitive treatment costs in India can hope for relief.
The nation's top drugmakers have started manufacturing key medicines for such diseases in the country.
India's largest drugmaker Sun Pharmaceutical Industries Ltd and its peers Cipla Ltd, Glenmark Pharmaceuticals Ltd, Cadila Healthcare Ltd and Biocon Ltd are making cancer drugs under the production-linked incentive (PLI) scheme, according to information shared by the department of pharmaceuticals with Mint. They are among the 55 companies selected for incentives to produce 175 high-value medicines in India.
At present, most cancer drugs are imported, making them prohibitively expensive. That's when India's cancer burden is expected to rise from 26.7 million life years or DALYS―the sum of healthy life lost to a disease-in 2021 to 29.8 million in 2025, according to data from the Indian Council of Medical Research (ICMR).
The PLI scheme is a "great boon" as cancer drugs will not only become cheaper in India, but South American and southern African nations will also benefit, said Shyam Aggarwal, chairperson, medical oncology department at Sir Ganga Ram Hospital, Delhi.
Dit verhaal komt uit de March 05, 2025-editie van Mint Hyderabad.
Abonneer u op Magzter GOLD voor toegang tot duizenden zorgvuldig samengestelde premiumverhalen en meer dan 9000 tijdschriften en kranten.
Bent u al abonnee? Aanmelden
MEER VERHALEN VAN Mint Hyderabad
Mint Hyderabad
How a bankruptcy legislation turned India’s banks around
A decade ago, the banking system was facing ballooning bad loans. Public sector banks were loaded with bad debts, and defaulting promoters retained control of failing companies while creditors waited to recover investments. The Insolvency and Bankruptcy Code (IBC), enacted in 2016, set out to change that.
1 mins
May 28, 2026
Mint Hyderabad
I-T return filings plateau as exemption thresholds rise
The decline in income tax return filings among individuals earning up to ₹5 lakh reflects policy changes rather than weaker tax compliance, according to Vikas Sharma, lead-personal tax at AKM Global.
1 mins
May 28, 2026
Mint Hyderabad
Blow to gaming as SC backs tax levy
Court upholds 28% GST, retrospective demand totalling ₹1.5 tn
1 min
May 28, 2026
Mint Hyderabad
Hurdles and hopes of aspiring cricketers
A new book explores stories of toil, poverty, rejection, politics, casteism and luck behind the glamour and glitz of a career in cricket
4 mins
May 28, 2026
Mint Hyderabad
Bond yields look attractive: bigger returns, bigger risks?
Investors are shifting from FDs to bonds for higher yields, underestimating the downsides
4 mins
May 28, 2026
Mint Hyderabad
Control, not just FDI, drives insurance M&A
Push for greater control may trigger consolidation in the insurance sector
2 mins
May 28, 2026
Mint Hyderabad
Air India, IndiGo cut domestic flights
Air India, IndiGo and Air India Express are temporarily reducing their domestic flights by 10-22% in the coming months, as the airlines seek to deal with the impact of surging jet fuel prices and relatively lower travel demand, according to officials.
1 min
May 28, 2026
Mint Hyderabad
From dirty dozen to IBC 2.0: India’s debt resolution shift
When Parliament took up a new bankruptcy code for passage in May 2016, the minister who replied to the debate in Lok Sabha, Jayant Sinha, mentioned its critical place in the overall economic agenda of the government—a friction-free exit for the corporate sector, complementing the policy support given to startups and entrepreneurship.
2 mins
May 28, 2026
Mint Hyderabad
The deeply satisfying comfort of Lithuanian food
From pink soups and potato dumplings to meat pies, the local cuisine is best enjoyed at women-run canteens
4 mins
May 28, 2026
Mint Hyderabad
How Pakistan is defying some of the world’s investing myths
This emerging economy is holding up well against a big oil shock
3 mins
May 28, 2026
Listen
Translate
Change font size

